Medications vs Psychotherapy for MDD: Comparing 5 Major Guidelines

How do you decide between psychotherapy versus medications for the treatment of major depressive disorder?

Depression severity is one of the criteria used to make this decision. This can be done by using clinician and/or patient-administered rating scales.

How does depression severity help with this decision of psychotherapy vs pharmacotherapy as treatment of major depressive disorder?

I reviewed the following 5 major guidelines to answer this question:

  1. APA (American Psychiatric Association) 2010 guidelines.
  2. NICE (National Institute for Health and Clinical Excellence) 2010 guidelines.
  3. CANMAT (Canadian Network for Mood and Anxiety Treatments) 2016 guidelines.
  4. British Association for Psychopharmacology 2015 guidelines.
  5. Royal Australian and New Zealand College of Psychiatrists 2015 guidelines.

HERE IS THE SUMMARY OF EACH GUIDELINE:

INTERETSTED IN LEARNING MORE?

WATCH ACADEMY CHAPTER:

This chapter (video discussion) will discuss these four guidelines comparing psychotherapy versus pharmacotherapy as first-line treatment for major depressive disorder. 

INTERESTED IN LEARNING MORE?

JOIN PSYCHIATRY EDUCATION FORUM ACADEMY MEMBERSHIP

This is a closed membership for medical professionals only.

  • 30+ Courses/Sections: Each chapter within these sections is of direct clinical relevance for your daily practice. 
  • Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice.
  • Coffee Club: contain short discussions with clinical experts in the field of psychiatry.
  • Essentials of Inpatient Psychiatry Book: All chapters from this book are included in the academy sections. 
  • Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases.
  • Conference Discounts: Academy members get discounted access at our conferences. 
  • Goal: is to have all important clinically relevant topics in one place for ease of access.
 

SUBSCRIBE TO OUR EMAIL NEWSLETTER:

Related Articles